Advertisement
Screener

Phibro Animal Health Corporation (PAHC) Material Contracts

Phibro Animal Health Corporation Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-26: Form 10-K; Exhibit 10.21; Description Restricted Stock Unit Award Agreement, dated as of July 1, 2026 by and between Daniel M. Bendheim and Phibro Animal Health Corporation..
  • 2026-08-26: Form 10-K; Exhibit 10.20; Description Employment Agreement, dated as of July 1, 2026, by and between Daniel M. Bendheim and Phibro Animal Health Corporation, including noncompetition and nonsolicitation agreement..
  • 2026-04-30: Form 8-K; Exhibit 10.1; Description Amendment No. 1, dated April 28, 2026, among Phibro Animal Health Corporation, Coöperatieve Rabobank U.A., New York Branch, as Administrative Agent, and the Lenders party thereto..
  • 2025-08-27: Form 10-K; Exhibit 10.22; Description Form of 2025 Restricted Stock Unit Agreement (Israel).
FiledFormExhibitDescription
2026-08-2610-K10.21Restricted Stock Unit Award Agreement, dated as of July 1, 2026 by and between Daniel M. Bendheim and Phibro Animal Health Corporation.
2026-08-2610-K10.20Employment Agreement, dated as of July 1, 2026, by and between Daniel M. Bendheim and Phibro Animal Health Corporation, including noncompetition and nonsolicitation agreement.
2026-04-308-K10.1Amendment No. 1, dated April 28, 2026, among Phibro Animal Health Corporation, Coöperatieve Rabobank U.A., New York Branch, as Administrative Agent, and the Lenders party thereto.
2025-08-2710-K10.22Form of 2025 Restricted Stock Unit Agreement (Israel)
2025-08-2710-K10.21Form of 2025 Restricted Stock Unit Agreement (U.S. and Brazil)
2025-08-2710-K10.20Severance Protection Letter, dated October 26, 2022, by and between Judith Weinstein and Phibro Animal Health Corporation.
2024-08-2810-K10.25Employment Offer Letter, dated October 10, 2023, by and between Glenn David and Phibro Animal Health Corporation, including noncompetition and nonsolicitation agreement.
2024-08-2810-K10.1Debt Commitment Letter, dated April 28, 2024, among Phibro Animal Health Corporation, Phibro Animal Health S.A., Coöperatieve Rabobank U.A., New York Branch, Compeer Financial, PCA and Citibank, N.A.
2024-07-098-K10.1Credit Agreement, dated July 3, 2024.
2023-08-3010-K10.18Executive Long-Term Incentive Agreement dated July 5, 2023 by and between Phibro Animal Health Corporation and Larry L. Miller.
2023-06-168-K10.1Amendment No. 2 to the Credit Agreement, dated June 16, 2023
2022-11-0910-Q10.1First Amendment to Amended and Restated Credit Agreement, among Phibro Animal Health Corporation, Bank of America, N.A. and each lender party thereto, dated as of November 8, 2022
2022-02-0910-Q10.25Severance Protection Letter, dated February 7, 2022, by and between Damian Finio and Phibro Animal Health Corporation
2021-08-2510-K10.24General Release and Separation Agreement, dated November 16, 2020, by and between Richard G. Johnson and Phibro Animal Health Corporation.
2021-04-228-K10.1Amended and Restated Credit Agreement, dated April 22, 2021
2020-11-0410-Q10.2Continuing Employment Letter, dated November 2, 2020, by and between Richard G. Johnson and Phibro Animal Health Corporation.
2020-11-0410-Q10.1Employment Offer Letter, dated September 14, 2020, by and between Damian L. Finio and Phibro Animal Health Corporation, including confidentiality and nondisclosure, employee invention, and noncompetition and nonsolicitation agreements.
2020-08-2610-K10.18Employment Offer Letter, dated May 6, 2019, by and between Rob Aukerman and Phibro Animal Health Corporation, including confidentiality and nondisclosure, employee invention, and noncompetition and nonsolicitation agreements.
2019-08-2710-K10.22Amendment to Employment Agreement, dated December 16, 2011, by and between Thomas G. Dagger and Phibro Animal Health Corporation.
2019-08-2710-K10.21Amendment to Employment Agreement, dated November 16, 2009, by and between Thomas G. Dagger and Phibro Animal Health Corporation.
2019-08-2710-K10.20Employment Agreement, dated November 3, 2006, by and between Thomas G. Dagger and Phibro Animal Health Corporation.
2018-11-0610-Q10.18Exhibit 10.18* First Amendment, dated July 31, 2018 to the Intellectual Property Purchase Agreement, drafted as of January 20, 2015, by and among MJ Biologics, Inc. and Phibro Animal Health Corporation
2018-05-078-K10.2Form of Restricted Stock Unit Award Agreement
2017-08-3010-K10.39to provide you with the retention bonuses described in this letter (this “Retention Letter Agreement") such that
2017-08-3010-K10.38of President Animal Health and Nutrition, US reporting to Larry Milter, Chief Operating Officer, effective July 1, 2016. Compensation:
2017-06-298-K10.1Credit Agreement, dated June 29, 2017
2016-12-238-K10.1Amendment No. 2 to Credit Agreement, dated December 23, 2016, among Phibro Animal Health Corporation, Bank of America, N.A., and Coöperatieve Rabobank U.A., New York Branch (f/k/a Coöperatieve Centrale Raiffeisen-Boerenleenbank, B.A., “Rabobank Nederland,” New York Branch)
2016-08-2910-K10.35AMENDMENT TO AMENDED AND
2016-01-198-K10.1Amendment No. 1 to Credit Agreement, dated January19, 2016, among Phibro Animal Health Corporation, Bank of America, N.A., and Coöperatieve Rabobank U.A., New York Branch (f/k/a Coöperatieve Centrale Raiffeisen-Boerenleenbank, B.A., “Rabobank Nederland,” New York Branch)
2015-09-1010-K10.34EXECUTIVE LONG-TERM INCENTIVE AGREEMENT
2015-05-1110-Q10.33Intellectual Property Purchase Agreement dated January 20, 2015 by and between MJ Biologics, Inc. and Phibro Animal Health Corporation
2014-04-238-K10.1Credit Agreement, dated April 16, 2014.